Write your message
Volume 6, Issue 1 (Winter 2021)                   J Obstet Gynecol Cancer Res 2021, 6(1): 10-15 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Bahadori F, Fakour Z, Redaei R, Khalkhali H R, Sahebazzamani Z. The Effect of Betamethasone on the Consequences of Late Preterm Pregnancy: A Double-Blind Randomized Clinical Trial. J Obstet Gynecol Cancer Res. 2021; 6 (1) :10-15
URL: http://jogcr.com/article-1-322-en.html
1- Associate Professor, Maternal and Childhood Obesity Research Center, Urmia University of Medical Sciences, Urmia, Iran
2- Associate Professor of Neonatology Department of Pediatric Disease, School of Medicine Shahid Motahari Hospital, Urmia University of Medical Sciences. Urmia, Iran , z.fakour@yahoo.com
3- Obstetrician-Gynecologist, Taleghani Hospital, Chalous, Iran
4- Associate Professor, Department of Biostatistics and Epidemiology, Patient Safety Research Center, Urmia University of Medical Sciences, Urmia, Iran
5- Master of Midwifery Maternal and Childhood Obesity Research Center, Urmia University of Medical Sciences, Urmia, Iran
Abstract:   (460 Views)
Background & Objective: This study aimed to assess the effect of betamethasone on neonatal and maternal complications of late preterm labor.
Materials and Methods: The women at the gestational age of 34 weeks to 36 weeks and 6 days who referred to Shahid Motahari Hospital, Urmia, Iran for premature labor or had a maternal indication of pregnancy termination were selected for this study. The participants were classified into the case group receiving two doses of 12 mg intramuscular betamethasone every 24 h or the control group who did not receive betamethasone. The incidence of respiratory distress syndrome (RDS), need for mechanical or noninvasive ventilation, days of stay in Neonatal Intensive Care Unit (NICU) or Neonatal Ward, umbilical arterial blood gases, maternal hyperglycemia, and wound infection were evaluated.
Results: A total of 200 pregnant women were enrolled with a mean age of 27.06±6.55 years. Out of 200 neonates, 52 cases had RDS of which 21 received betamethasone. The first-minute Apgar score was 6.96±0.75 in the control and 7.57±0.67 in the case groups (P<0.001). The incidence of RDS, need for surfactant administration, noninvasive ventilation, and days of stay at NICU or Neonatal Ward were significantly different between the study groups. However, because of the low number of cases (2 cases), we did not find a significant difference in the need for mechanical ventilation between the two groups (P=0.041). There was maternal hyperglycemia in 65% of women in the test group.
Conclusion: Administration of betamethasone in late premature pregnancies can be effective in the reduction of neonatal complications without any increase in maternal complications.
Full-Text [PDF 295 kb]   (290 Downloads) |   |   Full-Text (HTML)  (59 Views)  
Systematic Review: Original Research | Subject: Maternal Fetal Medicine
Received: 2020/09/13 | Accepted: 2020/11/19 | Published: 2021/01/1

References
1. Almassinokiani F, Sabouteh M, Soheilipour F, Kashanian M, Akbari P, Rahimzadeh N. Does antenatal Betamethasone improve neonatal outcome in late preterm births?. Int J Child Adolesc health. 2016;2(3):11-5.
2. Mirzamoradi M, Hasani Nejhad F, Jamali R, Heidar Z, Bakhtiyari M. Evaluation of the effect of antenatal betamethasone on neonatal respiratory morbidities in late preterm deliveries (34-37 weeks). J Matern.-Fetal Neonatal Med. 2020;33(15):2533-40. [DOI:10.1080/14767058.2018.1554051] [PMID]
3. Battarbee AN, Glover AV, Vladutiu CJ, Gyamfi-Bannerman C, Aliaga S, Manuck TA, et al. Risk factors associated with prolonged neonatal intensive care unit stay after threatened late preterm birth. J Matern.-Fetal Neonatal Med. 2019:1-6. [DOI:10.1080/14767058.2019.1623777] [PMID] [PMCID]
4. Moore H, Venugopalan V. Antenatal betamethasone prevented respiratory distress syndrome in late preterm infants. Arch Dis Child. 2018;103(4):218-. [DOI:10.1136/archdischild-2017-313632] [PMID]
5. Engle WA, Kominiarek MA. Late preterm infants, early term infants, and timing of elective deliveries. Clin Perinatol. 2008;35(2):325-41. [DOI:10.1016/j.clp.2008.03.003] [PMID]
6. Hillman NH, Pillow JJ, Ball MK, Polglase GR, Kallapur SG, Jobe AH. Antenatal and postnatal corticosteroid and resuscitation induced lung injury in preterm sheep. Respiratory research. 2009;10(1):124. [DOI:10.1186/1465-9921-10-124] [PMID] [PMCID]
7. Gyamfi-Bannerman C. ACOG CO™™ I™™ EE OPINION SUMMARY. 2017.
8. Ontela V, Dorairajan G, Bhat VB, Chinnakali P. Effect of antenatal steroids on respiratory morbidity of late preterm newborns: a randomized controlled trial. J Trop Pediatr. 2018;64(6):531-8. [DOI:10.1093/tropej/fmy001] [PMID]
9. Movahed F, Baricany A, Jafari M. Effect of betamethasone on neonatal respiratory failure in late preterm pregnancies. Journal of Gorgan University of Medical Sciences. 2015;17(4):16-20.
10. Sheldon B, Korones M. Complications En: Goldsmith J, Karotkin E. Assisted ventilation of the neonate United States of America: Saunders-Elsevier Inc. 2011:389-425. [DOI:10.1016/B978-1-4160-5624-9.00023-8]
11. Mansouri M, Seyedolshohadaei F, Setare S, Mazhari S. Effect of antenatal Betamethasone on prevention of respiratory distress syndrome among neonates with gestational age of 35-36 weeks. Journal of Gorgan University of Medical Sciences. 2010;12(3).
12. Porto AMF, Coutinho IC, Correia JB, Amorim MMR. Effectiveness of antenatal corticosteroids in reducing respiratory disorders in late preterm infants: randomised clinical trial. Bmj. 2011;342:d1696. [DOI:10.1136/bmj.d1696] [PMID] [PMCID]
13. Ventolini G, Neiger R, Mathews L, Adragna N, Belcastro M. Incidence of respiratory disorders in neonates born between 34 and 36 weeks of gestation following exposure to antenatal corticosteroids between 24 and 34 weeks of gestation. Am J Perinatol. 2008;25(02):079-83. [DOI:10.1055/s-2007-1022470] [PMID]
14. Shelton S, Boggess K, Smith T, Herbert W. Effect of betamethasone on maternal glucose. J Matern.-Fetal Neonatal Med. 2002;12(3):191-5. [DOI:10.1080/jmf.12.3.191.195] [PMID]

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


© 2021 CC BY-NC 4.0 | Journal of Obstetrics, Gynecology and Cancer Research (JOGCR)

Designed & Developed by : Yektaweb | Piblisher: Farname Inc.